Skip to main content

Phosphoenolpyruvate carboxykinase deficiency

This page has been archived.

It has not been reviewed recently and is not up to date. External links and references may no longer work.

Medical Professionals

Professional Reference articles are designed for health professionals to use. They are written by UK doctors and based on research evidence, UK and European Guidelines. You may find one of our health articles more useful.

Continue reading below

Introduction

Phosphoenolpyruvate carboxykinase is an important enzyme in gluconeogenesis. It is found in both the cytosol and mitochondria of the liver cells. The enzyme is regulated by insulin, glucocorticoids, cyclic adenosine monophosphate (cAMP) and diet to maintain glucose homeostasis.

Two types of phosphoenolpyruvate carboxykinase exist:

  • PCK1, PEPCK1 - soluble in the cytosol.1

  • PCK2, PEPCK2 - soluble in the mitochondria.2

Epidemiology12

  • Both conditions are extremely rare.

  • They have been reported in siblings.

  • Both are autosomal recessive inheritance.

  • The enzyme mutation in PCK1 is at gene map locus 20q13.31, and in PCK2 at 14q11.2-q12.

Continue reading below

Presentation

  • Hypoglycaemia - difficulty keeping blood sugars high.

  • Drowsiness due to hypoglycaemia.

  • Failure to thrive.

  • Metabolic acidosis from accumulation of lactic acid.

  • Mild icterus with hepatomegaly.

  • Generalised muscle weakness.

Deficiency of the enzyme can cause persistent neonatal hypoglycaemia but failure of downregulation has also been linked with type 2 diabetes mellitus and, especially, maturity-onset diabetes in the young (MODY).3

Investigations

  • Fasting provokes lactic acidosis.

  • LFTs are abnormal and liver biopsy shows giant cell hepatitis.

  • Culture of skin fibroblasts shows reduced activity of phosphoenolpyruvate carboxykinase.

Continue reading below

Differential diagnosis

Other causes of neonatal hypoglycaemia - for example:

  • Glucose-6-phosphatase deficiency

  • Fructose-1,6,-diphosphatase deficiency

  • Pyruvate carboxylase deficiency

Management and prognosis

  • Presumably, regular feeding would prevent or reduce hypoglycaemia but the impression is of a relentless disease that causes early death (within the first six months).12

  • Autopsy shows considerable fatty infiltration of both the liver and the kidneys. Fatty infiltration of other tissues also occurs but is less marked.

  • Genetic counselling may be given as for any other autosomal recessive disorder. There is no literature about antenatal detection.

Further reading and references

  1. Phosphoenolpyruvate carboxykinase 1 - Soluble, PCK1; Online Mendelian Inheritance in Man (OMIM)
  2. Phosphoenolpyruvate carboxykinase 2 - Mitochondrial, PCK2; Online Mendelian Inheritance in Man (OMIM)
  3. Cao H, van der Veer E, Ban MR, et al; Promoter polymorphism in PCK1 (phosphoenolpyruvate carboxykinase gene) associated with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2004 Feb;89(2):898-903.

Continue reading below

Article history

The information on this page is written and peer reviewed by qualified clinicians.

flu eligibility checker

Ask, share, connect.

Browse discussions, ask questions, and share experiences across hundreds of health topics.

symptom checker

Feeling unwell?

Assess your symptoms online for free